30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Esmeralda Scipilliti et al. | Abstract 2749 | ESTRO | 2024
EBUS-guided Fiducial Placement for SBRT in Mediastinal Nodal Oligometastases
Ilaria Morelli et al. | Abstract 1442 | ESTRO | 2024
CyberKnife and Gamma Knife-based SRT for Head and Neck Paragangliomas: A Single-Center Experience
Viola Salvestrini et al. | Abstract 1906 | ESTRO | 2024
Stereotactic Radiosurgery for Intracranial Meningiomas in Elderly Patients: A Retrospective Analysis
Carolin Senger et al. | Abstract 2074 | ESTRO | 2024
Evaluation of Recurrence Patterns after Postoperative Radiosurgery for Brain Metastases
Luca Visani et al. | Abstract 1772 | ESTRO | 2024
Pattern of Recurrence after Fractionated Stereotactic Body Reirradiation in Glioblastoma Recurrence
Agathe Margulies et al. | Abstract 671 | ESTRO | 2024
CYBERNEO Trial: Update of Results at 14 Years of Follow-up
Syrine Ben Dhia et al. | Abstract 413 | ESTRO | 2024
Acute Toxicity from PACE-C Comparing Stereotactic Body Radiotherapy (SBRT) with Moderate Hypofractionation (MHRT)
Alison Tree et al. | Abstract 3395 | ESTRO | 2024
Reappraising Prognostic Factors after SRS/FSRT of Brain Metastases in the era of Targeted Therapies
Christoph A Fink et al. | Abstract 1044 | ESTRO | 2024
Preoperative Single-fraction RT for Earlystage BC: Preliminary Results from CRYSTAL Phase I/II Study
Maria Alessia Zerella et al. | Abstract 2613 | ESTRO | 2024
Outcomes of a Phase II Trial of High-dose Online-Adaptive SBRT for Abdominal Oligometastases
Lucy A. van Werkhoven et al. | Abstract 613 | ESTRO | 2024
Patterns of Care and Outcome of Liver SBRT: Results from a Multicentre National Quality Project
Pieter Deseyne et al. | Abstract 735 | ESTRO | 2024
Outcomes of Pelvic Reirradiation with Stereotactic Radiotherapy for Gynaecological Cancer Recurrence
Benjamin J Thomas et al. | Abstract 2829 | ESTRO | 2024
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Binnaz Yasar, Yae-Eun Suh, Ewan Chapman, Luke Nicholls, Daniel Henderson, Caroline Jones, Kirsty Morrison | Abstract 491 | ESTRO | 2024
Stereotactic Radiosurgery for Residual, Recurrent, and Metastatic Hemangiopericytomas: A Single Institution Retrospective Experience
Amirhossein Akhavan-Sigari et al. | RSS | 2024
A Proof of Concept for MR-only Workflow in CyberKnife Intracranial Radiosurgery
Evaggelos Pantelis et al. | Abstract 2146 | ESTRO | 2024
Evaluation of Intrafractional Movements for Brain and Prostate SBRT Treatments with CyberKnife
Gábor Stelczer et al. | Abstract 2291 | ESTRO | 2024
A Geometric Parameter to Predict the Risk of Exceeding Tolerance Doses During Pancreas SBRT
Mauro Loi et al. | Abstract 2098 | ESTRO | 2024
Dosimetric Comparison of Liver SBRT Treatments with Conventional Linear Accelerator and CyberKnife
Enikő Koszta et al. | Abstract 2199 | ESTRO | 2024
The UPRATE trial: Feasibility of Seminal Vesicle PTV-margin Reduction with Online Adaptive SBRT
Victor J. Brand et al. | Abstract 2416 | ESTRO | 2024
SBRT and Systemic Therapy for Patients with Oligometastatic Renal Cell Carcinoma
Miriam Torrisi et al. | Abstract 1724 | ESTRO | 2024
SABR for Liver De Novo, Repeat, and Induced Oligometastatic Disease
Miriam Torrisi et al. | Abstract 1735 | ESTRO | 2024
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Esmeralda Scipilliti et al. | Abstract 2749 | ESTRO | 2024